2041 - 2050 of 6433 Results
Title
Year
-
OPENTitle: Proteolytic activities of extracellular vesicles attenuate A-synuclein aggregationJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-025-01122-9Best OA location URL: https://www.nature.com/articles/s41531-025-01122-9.pdfCitation Count: 0
- Determination of optimal vibration dose to treat Parkinson's disease gait symptoms: A clinical trial2024OPENTitle: Determination of optimal vibration dose to treat Parkinson's disease gait symptoms: A clinical trialJournal Name: Clinical Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 10Issue #:Start Page: 100248End Page: 100248Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.prdoa.2024.100248Best OA location URL: http://dx.doi.org/10.1016/j.prdoa.2024.100248Citation Count: 0
-
OPENTitle: Radiolabeled Aminopyrazoles as Novel Isoform Selective Probes for pJNK3 QuantificationJournal Name: ACS Medicinal Chemistry LettersPublisher: American Chemical Society (ACS)Vol: 13Issue #: 10Start Page: 1606End Page: 1614Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/acsmedchemlett.2c00278Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/9575163Citation Count: 4
-
OPENTitle: Disease-Specific Regions Outperform Whole-Brain Approaches in Identifying Progressive Supranuclear Palsy: A Multicentric MRI StudyJournal Name: Frontiers in NeurosciencePublisher: Frontiers Media SAVol: 11Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnins.2017.00100Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnins.2017.00100/pdfCitation Count: 15
-
OPENTitle: Coordinated reset vibrotactile stimulation shows prolonged improvement in Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 33Issue #: 1Start Page: 179End Page: 180Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.27223Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.27223Citation Count: 37
-
OPENTitle: α-Synuclein fibril-induced inclusion spread in rats and mice correlates with dopaminergic NeurodegenerationJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 105Issue #:Start Page: 84End Page: 98Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2017.05.014Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/5701756Citation Count: 154
-
OPENTitle: Alpha1-chimaerin, a Rac1 GTPase-activating protein, is expressed at reduced mRNA levels in the brain of Alzheimer’s disease patientsJournal Name: Neuroscience LettersPublisher: Elsevier BVVol: 591Issue #:Start Page: 19End Page: 24Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neulet.2015.02.013Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/4382517Citation Count: 11
-
OPENTitle: Neurogenesis in Cancun: where science meets the seaJournal Name: DevelopmentPublisher: The Company of BiologistsVol: 143Issue #: 10Start Page: 1649End Page: 1654Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1242/dev.138412Best OA location URL: https://journals.biologists.com/dev/article-pdf/143/10/1649/1842172/dev138412.pdfCitation Count: 0
-
OPENTitle: The G2019S variant of leucine-rich repeat kinase 2 (LRRK2) alters endolysosomal trafficking by impairing the function of the GTPase RAB8AJournal Name: Journal of Biological ChemistryPublisher: Elsevier BVVol: 294Issue #: 13Start Page: 4738End Page: 4758Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1074/jbc.ra118.005008Best OA location URL: http://www.jbc.org/article/S0021925820355307/pdfCitation Count: 70
-
OPENTitle: New ghrelin agonist, HM01 alleviates constipation and L‐dopa‐delayed gastric emptying in 6‐hydroxydopamine rat model of Parkinson's diseaseJournal Name: Neurogastroenterology & MotilityPublisher: WileyVol: 26Issue #: 12Start Page: 1771End Page: 1782Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/nmo.12459Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/4457321Citation Count: 53